

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 7.55535204 |
| 2 | regulation of penile erection (GO:0060405) | 5.88534745 |
| 3 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.82751041 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.76768548 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.63225446 |
| 6 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.63010025 |
| 7 | behavioral response to nicotine (GO:0035095) | 5.53596976 |
| 8 | behavioral response to cocaine (GO:0048148) | 5.13352399 |
| 9 | postsynaptic membrane organization (GO:0001941) | 5.10261061 |
| 10 | norepinephrine metabolic process (GO:0042415) | 4.95495833 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.93578843 |
| 12 | vocalization behavior (GO:0071625) | 4.87490713 |
| 13 | limb bud formation (GO:0060174) | 4.82706886 |
| 14 | behavioral response to ethanol (GO:0048149) | 4.81413641 |
| 15 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 4.78826679 |
| 16 | response to histamine (GO:0034776) | 4.66826620 |
| 17 | fucose catabolic process (GO:0019317) | 4.61306142 |
| 18 | L-fucose metabolic process (GO:0042354) | 4.61306142 |
| 19 | L-fucose catabolic process (GO:0042355) | 4.61306142 |
| 20 | short-term memory (GO:0007614) | 4.54015146 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27646646 |
| 22 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.25300386 |
| 23 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.25300386 |
| 24 | cellular response to zinc ion (GO:0071294) | 4.22369379 |
| 25 | lateral sprouting from an epithelium (GO:0060601) | 4.22255238 |
| 26 | chemosensory behavior (GO:0007635) | 4.17838135 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.11681757 |
| 28 | positive regulation of dendritic spine development (GO:0060999) | 4.08157353 |
| 29 | behavioral defense response (GO:0002209) | 3.98621125 |
| 30 | behavioral fear response (GO:0001662) | 3.98621125 |
| 31 | synaptic vesicle maturation (GO:0016188) | 3.96453101 |
| 32 | synaptic transmission, dopaminergic (GO:0001963) | 3.93935172 |
| 33 | presynaptic membrane organization (GO:0097090) | 3.92340686 |
| 34 | cardiac left ventricle morphogenesis (GO:0003214) | 3.81744785 |
| 35 | tryptophan catabolic process (GO:0006569) | 3.78103594 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 3.78103594 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 3.78103594 |
| 38 | regulation of dendritic spine development (GO:0060998) | 3.76226238 |
| 39 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.74035230 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.67914699 |
| 41 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.61552279 |
| 42 | fear response (GO:0042596) | 3.61041144 |
| 43 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.50777354 |
| 44 | indolalkylamine metabolic process (GO:0006586) | 3.48872457 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.46094352 |
| 46 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.45165816 |
| 47 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.45165816 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.44042558 |
| 49 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.43948603 |
| 50 | negative regulation of cyclase activity (GO:0031280) | 3.42819484 |
| 51 | regulation of action potential (GO:0098900) | 3.42128856 |
| 52 | regulation of cilium movement (GO:0003352) | 3.41202982 |
| 53 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.40550689 |
| 54 | kynurenine metabolic process (GO:0070189) | 3.40094520 |
| 55 | ubiquinone biosynthetic process (GO:0006744) | 3.38401771 |
| 56 | embryonic skeletal joint morphogenesis (GO:0060272) | 3.36281370 |
| 57 | glutathione biosynthetic process (GO:0006750) | 3.35515155 |
| 58 | cullin deneddylation (GO:0010388) | 3.32083230 |
| 59 | platelet dense granule organization (GO:0060155) | 3.30733149 |
| 60 | nonmotile primary cilium assembly (GO:0035058) | 3.30613509 |
| 61 | negative regulation of lyase activity (GO:0051350) | 3.29510350 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.28979146 |
| 63 | amine catabolic process (GO:0009310) | 3.28979146 |
| 64 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.28864310 |
| 65 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.28832180 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.27229518 |
| 67 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.26991918 |
| 68 | regulation of dopamine metabolic process (GO:0042053) | 3.26810532 |
| 69 | regulation of catecholamine metabolic process (GO:0042069) | 3.26810532 |
| 70 | mesonephros development (GO:0001823) | 3.26377742 |
| 71 | negative regulation of telomere maintenance (GO:0032205) | 3.25408571 |
| 72 | ubiquinone metabolic process (GO:0006743) | 3.23714111 |
| 73 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.23201531 |
| 74 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.22490025 |
| 75 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21824548 |
| 76 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.20525651 |
| 77 | synaptic vesicle exocytosis (GO:0016079) | 3.19508230 |
| 78 | regulation of neurotransmitter uptake (GO:0051580) | 3.19227969 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18200717 |
| 80 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.17874392 |
| 81 | membrane assembly (GO:0071709) | 3.16152093 |
| 82 | serotonin metabolic process (GO:0042428) | 3.13725400 |
| 83 | reflex (GO:0060004) | 3.11727876 |
| 84 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.10278978 |
| 85 | negative regulation of cAMP metabolic process (GO:0030815) | 3.09410469 |
| 86 | protein polyglutamylation (GO:0018095) | 3.08894323 |
| 87 | tryptophan metabolic process (GO:0006568) | 3.08168941 |
| 88 | regulation of mitochondrial depolarization (GO:0051900) | 3.07330725 |
| 89 | organ induction (GO:0001759) | 3.06275892 |
| 90 | protein-cofactor linkage (GO:0018065) | 3.03772633 |
| 91 | lung lobe morphogenesis (GO:0060463) | 3.02891279 |
| 92 | response to pheromone (GO:0019236) | 3.00902025 |
| 93 | positive regulation of action potential (GO:0045760) | 2.99934849 |
| 94 | cellular ketone body metabolic process (GO:0046950) | 2.99536727 |
| 95 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.99014347 |
| 96 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.99014347 |
| 97 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 2.98054890 |
| 98 | catecholamine metabolic process (GO:0006584) | 2.97703139 |
| 99 | catechol-containing compound metabolic process (GO:0009712) | 2.97703139 |
| 100 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97265370 |
| 101 | protein deneddylation (GO:0000338) | 2.95851753 |
| 102 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.95659532 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92857671 |
| 104 | nucleobase catabolic process (GO:0046113) | 2.92561252 |
| 105 | synaptic transmission, cholinergic (GO:0007271) | 2.92265410 |
| 106 | respiratory chain complex IV assembly (GO:0008535) | 2.89923377 |
| 107 | response to epinephrine (GO:0071871) | 2.88994888 |
| 108 | cell migration in hindbrain (GO:0021535) | 2.88912909 |
| 109 | regulation of microtubule-based movement (GO:0060632) | 2.87534144 |
| 110 | positive regulation of protein export from nucleus (GO:0046827) | 2.87441164 |
| 111 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.86149626 |
| 112 | detection of light stimulus involved in visual perception (GO:0050908) | 2.86149626 |
| 113 | neural tube formation (GO:0001841) | 2.85349853 |
| 114 | epithelial cilium movement (GO:0003351) | 2.85129557 |
| 115 | DNA deamination (GO:0045006) | 2.84568236 |
| 116 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.83669085 |
| 117 | cornea development in camera-type eye (GO:0061303) | 2.82378290 |
| 118 | alanine transport (GO:0032328) | 2.82094847 |
| 119 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.79364724 |
| 120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78807978 |
| 121 | protein complex biogenesis (GO:0070271) | 2.78379560 |
| 122 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.78361772 |
| 123 | NADH dehydrogenase complex assembly (GO:0010257) | 2.78361772 |
| 124 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.78361772 |
| 125 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.77280458 |
| 126 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.77163714 |
| 127 | cilium morphogenesis (GO:0060271) | 2.76473199 |
| 128 | indole-containing compound metabolic process (GO:0042430) | 2.75760093 |
| 129 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75435396 |
| 130 | induction of positive chemotaxis (GO:0050930) | 2.75347095 |
| 131 | ketone body metabolic process (GO:1902224) | 2.75249764 |
| 132 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74774168 |
| 133 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.74698107 |
| 134 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.74065536 |
| 135 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.73637408 |
| 136 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.70744157 |
| 137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.70102225 |
| 138 | dopamine metabolic process (GO:0042417) | 2.70036232 |
| 139 | proline transport (GO:0015824) | 2.69351057 |
| 140 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.68773930 |
| 141 | glycerophospholipid catabolic process (GO:0046475) | 2.67872280 |
| 142 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.66931350 |
| 143 | fucosylation (GO:0036065) | 2.66606103 |
| 144 | muscle cell cellular homeostasis (GO:0046716) | 2.66274322 |
| 145 | response to misfolded protein (GO:0051788) | 2.65907054 |
| 146 | neuronal action potential (GO:0019228) | 2.65818033 |
| 147 | kidney morphogenesis (GO:0060993) | 2.65500180 |
| 148 | quinone biosynthetic process (GO:1901663) | 2.64692239 |
| 149 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.64059344 |
| 150 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.63810356 |
| 151 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.63810356 |
| 152 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.61717074 |
| 153 | cytochrome complex assembly (GO:0017004) | 2.61528150 |
| 154 | neuronal action potential propagation (GO:0019227) | 2.60599006 |
| 155 | neuron-neuron synaptic transmission (GO:0007270) | 2.60071353 |
| 156 | nephron tubule morphogenesis (GO:0072078) | 2.59611845 |
| 157 | nephron epithelium morphogenesis (GO:0072088) | 2.59611845 |
| 158 | activation of protein kinase B activity (GO:0032148) | 2.58094415 |
| 159 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.57878161 |
| 160 | enteric nervous system development (GO:0048484) | 2.57803860 |
| 161 | regulation of synapse organization (GO:0050807) | 2.57723744 |
| 162 | sulfation (GO:0051923) | 2.57320404 |
| 163 | desmosome organization (GO:0002934) | 2.57304886 |
| 164 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.57291977 |
| 165 | negative regulation of microtubule polymerization (GO:0031115) | 2.57264279 |
| 166 | dopamine receptor signaling pathway (GO:0007212) | 2.57049372 |
| 167 | protein localization to synapse (GO:0035418) | 2.56907845 |
| 168 | positive regulation of fatty acid transport (GO:2000193) | 2.56203684 |
| 169 | auditory behavior (GO:0031223) | 2.51917136 |
| 170 | primary amino compound metabolic process (GO:1901160) | 2.51917008 |
| 171 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.51837711 |
| 172 | cilium organization (GO:0044782) | 2.51104424 |
| 173 | dendritic spine morphogenesis (GO:0060997) | 2.50051489 |
| 174 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.49687713 |
| 175 | positive regulation of prostaglandin secretion (GO:0032308) | 2.47120047 |
| 176 | regulation of postsynaptic membrane potential (GO:0060078) | 2.46837098 |
| 177 | cilium assembly (GO:0042384) | 2.46272919 |
| 178 | smooth muscle cell differentiation (GO:0051145) | 2.46075854 |
| 179 | peristalsis (GO:0030432) | 2.44930468 |
| 180 | cellular response to interferon-alpha (GO:0035457) | 2.44832615 |
| 181 | regulation of hexokinase activity (GO:1903299) | 2.43901675 |
| 182 | regulation of glucokinase activity (GO:0033131) | 2.43901675 |
| 183 | exogenous drug catabolic process (GO:0042738) | 2.43355977 |
| 184 | retinal cone cell development (GO:0046549) | 2.42331336 |
| 185 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.41396614 |
| 186 | negative regulation of mast cell activation (GO:0033004) | 2.41084115 |
| 187 | inositol phosphate catabolic process (GO:0071545) | 2.39197038 |
| 188 | sperm motility (GO:0030317) | 2.39037338 |
| 189 | piRNA metabolic process (GO:0034587) | 2.38619236 |
| 190 | mitochondrion morphogenesis (GO:0070584) | 2.38206484 |
| 191 | ATP synthesis coupled proton transport (GO:0015986) | 2.38158681 |
| 192 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.38158681 |
| 193 | axoneme assembly (GO:0035082) | 2.37178715 |
| 194 | aromatic amino acid family catabolic process (GO:0009074) | 2.36990277 |
| 195 | auditory receptor cell stereocilium organization (GO:0060088) | 2.35415057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.70896873 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.77712398 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.68291845 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.29619956 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11340492 |
| 6 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.94542565 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93824962 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.86816575 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.82139249 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.81675843 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.73438661 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71457052 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.69055569 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.64309564 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.59677033 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.54544725 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.51325595 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48074773 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807014 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46807014 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39086644 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35418659 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28620889 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.28465615 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20975733 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16854331 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13067668 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09134328 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.06323733 |
| 30 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91454195 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.91441160 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.87003367 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81280393 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.78303574 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76805544 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.75780528 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75177730 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.69875736 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69380493 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66104074 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65872362 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58746250 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56687997 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56586422 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56438154 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55849061 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53401070 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53082989 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47796515 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47380555 |
| 51 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46996395 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43878511 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42364262 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41280534 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41129703 |
| 56 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40942883 |
| 57 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40942883 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39929521 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39926883 |
| 60 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.38323085 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35846015 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35846015 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.35825020 |
| 64 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34715613 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.34301348 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34002017 |
| 67 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33280545 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32717992 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32607295 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31628247 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31628247 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31615072 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28631522 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28413560 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27566331 |
| 76 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27178000 |
| 77 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26450667 |
| 78 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26450667 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26054089 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25276006 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 1.23911642 |
| 82 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.22018737 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21949910 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20751583 |
| 85 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20120553 |
| 86 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.17586175 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16861341 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.16008476 |
| 89 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.15910795 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14797832 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14598605 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12335552 |
| 93 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12189346 |
| 94 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11498732 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11241564 |
| 96 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10295771 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09678060 |
| 98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07374019 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05411187 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05200619 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03815068 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03584450 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02927819 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02779967 |
| 105 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02210970 |
| 106 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.01687524 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01681548 |
| 108 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01613022 |
| 109 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01557701 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01521608 |
| 111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00135992 |
| 112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99798608 |
| 113 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99595737 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99242750 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98805397 |
| 116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98409661 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98166423 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97809935 |
| 119 | * FUS_26573619_Chip-Seq_HEK293_Human | 0.97274190 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94896265 |
| 121 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93032521 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92334379 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91921417 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91714486 |
| 125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91632213 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90344565 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89965568 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89328936 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88275373 |
| 130 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87446969 |
| 131 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87082402 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86155407 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84577514 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83867781 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82834865 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82190931 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82161826 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81595283 |
| 139 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80820056 |
| 140 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.80694488 |
| 141 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80318576 |
| 142 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80260089 |
| 143 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79992495 |
| 144 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78759903 |
| 145 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78560414 |
| 146 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77715990 |
| 147 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77191047 |
| 148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76552967 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.75213130 |
| 150 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.73832639 |
| 151 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.73695014 |
| 152 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.73575285 |
| 153 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71384151 |
| 154 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.70668490 |
| 155 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.69777345 |
| 156 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68750968 |
| 157 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.68590893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 6.33098611 |
| 2 | MP0004381_abnormal_hair_follicle | 5.83233384 |
| 3 | MP0000383_abnormal_hair_follicle | 4.04826789 |
| 4 | MP0003879_abnormal_hair_cell | 3.59203694 |
| 5 | MP0002163_abnormal_gland_morphology | 3.18155842 |
| 6 | MP0000372_irregular_coat_pigmentation | 3.17768203 |
| 7 | MP0005409_darkened_coat_color | 3.06327630 |
| 8 | MP0010678_abnormal_skin_adnexa | 2.93524457 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.86724053 |
| 10 | MP0002132_abnormal_respiratory_system | 2.63385843 |
| 11 | MP0000566_synostosis | 2.58929542 |
| 12 | MP0003195_calcinosis | 2.57472304 |
| 13 | MP0002090_abnormal_vision | 2.56004064 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.53961872 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.45476276 |
| 16 | MP0003011_delayed_dark_adaptation | 2.42259357 |
| 17 | MP0003122_maternal_imprinting | 2.32451466 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.31366231 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.31098174 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 2.22661003 |
| 21 | MP0004043_abnormal_pH_regulation | 2.21336526 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 2.13845290 |
| 23 | MP0002638_abnormal_pupillary_reflex | 2.07264434 |
| 24 | MP0001529_abnormal_vocalization | 2.06559981 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 2.04942107 |
| 26 | MP0010030_abnormal_orbit_morphology | 2.03238286 |
| 27 | MP0004142_abnormal_muscle_tone | 1.96289617 |
| 28 | MP0003880_abnormal_central_pattern | 1.92034392 |
| 29 | MP0004133_heterotaxia | 1.91432972 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.90129274 |
| 31 | MP0003787_abnormal_imprinting | 1.87302848 |
| 32 | MP0005187_abnormal_penis_morphology | 1.84958389 |
| 33 | MP0008872_abnormal_physiological_respon | 1.83638590 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.80179988 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.77263618 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.75562869 |
| 37 | MP0003646_muscle_fatigue | 1.71183678 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.70457373 |
| 39 | MP0009046_muscle_twitch | 1.69798049 |
| 40 | MP0004858_abnormal_nervous_system | 1.67899658 |
| 41 | MP0005253_abnormal_eye_physiology | 1.67869194 |
| 42 | MP0000647_abnormal_sebaceous_gland | 1.66484081 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.64238901 |
| 44 | MP0000778_abnormal_nervous_system | 1.63687400 |
| 45 | MP0005451_abnormal_body_composition | 1.62429444 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.62247145 |
| 47 | MP0005408_hypopigmentation | 1.61290490 |
| 48 | MP0001485_abnormal_pinna_reflex | 1.58577632 |
| 49 | MP0003828_pulmonary_edema | 1.58371202 |
| 50 | MP0004147_increased_porphyrin_level | 1.58367924 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.57600564 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.56138755 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.55640094 |
| 54 | MP0000631_abnormal_neuroendocrine_gland | 1.53404616 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.51763347 |
| 56 | MP0002282_abnormal_trachea_morphology | 1.46558606 |
| 57 | MP0003121_genomic_imprinting | 1.46102585 |
| 58 | MP0009745_abnormal_behavioral_response | 1.45792978 |
| 59 | MP0002064_seizures | 1.43763380 |
| 60 | MP0003938_abnormal_ear_development | 1.43755908 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 1.43285810 |
| 62 | MP0001970_abnormal_pain_threshold | 1.39635069 |
| 63 | MP0002938_white_spotting | 1.38179770 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.37466063 |
| 65 | MP0002184_abnormal_innervation | 1.34885407 |
| 66 | MP0004270_analgesia | 1.26700485 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.23781897 |
| 68 | MP0002254_reproductive_system_inflammat | 1.22397734 |
| 69 | MP0002272_abnormal_nervous_system | 1.18257269 |
| 70 | MP0002928_abnormal_bile_duct | 1.18146782 |
| 71 | MP0002160_abnormal_reproductive_system | 1.18126950 |
| 72 | MP0000049_abnormal_middle_ear | 1.16723840 |
| 73 | MP0005389_reproductive_system_phenotype | 1.15973656 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.15028903 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 1.14855458 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.13521746 |
| 77 | MP0001919_abnormal_reproductive_system | 1.12042247 |
| 78 | MP0001188_hyperpigmentation | 1.10983972 |
| 79 | MP0000427_abnormal_hair_cycle | 1.07414439 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.07069190 |
| 81 | MP0001905_abnormal_dopamine_level | 1.06073898 |
| 82 | MP0005360_urolithiasis | 1.04672434 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.02711497 |
| 84 | MP0009115_abnormal_fat_cell | 1.02581017 |
| 85 | MP0005083_abnormal_biliary_tract | 1.02233506 |
| 86 | MP0005195_abnormal_posterior_eye | 1.01182157 |
| 87 | MP0008789_abnormal_olfactory_epithelium | 1.00886081 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.99500225 |
| 89 | MP0002102_abnormal_ear_morphology | 0.97751674 |
| 90 | MP0001984_abnormal_olfaction | 0.97525256 |
| 91 | MP0008995_early_reproductive_senescence | 0.96901136 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.96542736 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.95054813 |
| 94 | MP0001486_abnormal_startle_reflex | 0.95014923 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.94682691 |
| 96 | MP0000026_abnormal_inner_ear | 0.92754492 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.91735653 |
| 98 | MP0002557_abnormal_social/conspecific_i | 0.91394599 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.91370469 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.91335065 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.90127489 |
| 102 | MP0005499_abnormal_olfactory_system | 0.90127489 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.88749475 |
| 104 | MP0002229_neurodegeneration | 0.88447961 |
| 105 | MP0003119_abnormal_digestive_system | 0.87856092 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.86990412 |
| 107 | MP0000579_abnormal_nail_morphology | 0.86833657 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.86696747 |
| 109 | MP0004742_abnormal_vestibular_system | 0.86114872 |
| 110 | MP0009379_abnormal_foot_pigmentation | 0.86102116 |
| 111 | MP0009250_abnormal_appendicular_skeleto | 0.85228565 |
| 112 | MP0005365_abnormal_bile_salt | 0.84269707 |
| 113 | MP0003718_maternal_effect | 0.83566910 |
| 114 | MP0001958_emphysema | 0.83238734 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.83152589 |
| 116 | MP0002882_abnormal_neuron_morphology | 0.82880506 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.82817369 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.82582069 |
| 119 | MP0004085_abnormal_heartbeat | 0.81167327 |
| 120 | MP0003878_abnormal_ear_physiology | 0.78827902 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.78827902 |
| 122 | MP0000920_abnormal_myelination | 0.77810606 |
| 123 | MP0003283_abnormal_digestive_organ | 0.77642927 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.77375176 |
| 125 | MP0009780_abnormal_chondrocyte_physiolo | 0.77301687 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.76525416 |
| 127 | MP0001177_atelectasis | 0.75370606 |
| 128 | MP0005085_abnormal_gallbladder_physiolo | 0.74179837 |
| 129 | MP0004885_abnormal_endolymph | 0.73498955 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.71951823 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.71839664 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.70427223 |
| 133 | MP0000537_abnormal_urethra_morphology | 0.70272173 |
| 134 | MP0002133_abnormal_respiratory_system | 0.69791494 |
| 135 | MP0005388_respiratory_system_phenotype | 0.69791494 |
| 136 | MP0001440_abnormal_grooming_behavior | 0.68493385 |
| 137 | MP0004811_abnormal_neuron_physiology | 0.68391287 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.67079632 |
| 139 | MP0001963_abnormal_hearing_physiology | 0.65786099 |
| 140 | MP0005386_behavior/neurological_phenoty | 0.65262190 |
| 141 | MP0004924_abnormal_behavior | 0.65262190 |
| 142 | MP0003329_amyloid_beta_deposits | 0.65004765 |
| 143 | MP0002735_abnormal_chemical_nociception | 0.64910298 |
| 144 | MP0008874_decreased_physiological_sensi | 0.64435972 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.63046205 |
| 146 | MP0002822_catalepsy | 0.61683510 |
| 147 | MP0004510_myositis | 0.60554891 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.59429838 |
| 149 | MP0002736_abnormal_nociception_after | 0.58987522 |
| 150 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58504097 |
| 151 | MP0009764_decreased_sensitivity_to | 0.58118890 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.57393366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Upper limb muscle weakness (HP:0003484) | 5.55509308 |
| 2 | Humeroradial synostosis (HP:0003041) | 5.19079298 |
| 3 | Synostosis involving the elbow (HP:0003938) | 5.19079298 |
| 4 | Nasolacrimal duct obstruction (HP:0000579) | 4.90196891 |
| 5 | Conical tooth (HP:0000698) | 4.68866134 |
| 6 | Premature skin wrinkling (HP:0100678) | 4.62024739 |
| 7 | Short chin (HP:0000331) | 4.55655282 |
| 8 | Absent eyebrow (HP:0002223) | 4.45437819 |
| 9 | Aplasia involving bones of the extremities (HP:0009825) | 4.31701573 |
| 10 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.31701573 |
| 11 | Aplasia of the phalanges of the hand (HP:0009802) | 4.31701573 |
| 12 | Pancreatic cysts (HP:0001737) | 4.25406107 |
| 13 | Abnormality of the lacrimal duct (HP:0011481) | 4.20894831 |
| 14 | Abnormality of midbrain morphology (HP:0002418) | 4.15515789 |
| 15 | Molar tooth sign on MRI (HP:0002419) | 4.15515789 |
| 16 | True hermaphroditism (HP:0010459) | 3.99189464 |
| 17 | Concave nail (HP:0001598) | 3.85811269 |
| 18 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.84676356 |
| 19 | Abnormality of alanine metabolism (HP:0010916) | 3.84676356 |
| 20 | Hyperalaninemia (HP:0003348) | 3.84676356 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.83510224 |
| 22 | Microglossia (HP:0000171) | 3.82780695 |
| 23 | Abnormality of the nasolacrimal system (HP:0000614) | 3.82753505 |
| 24 | Congenital stationary night blindness (HP:0007642) | 3.74535460 |
| 25 | Anteriorly placed anus (HP:0001545) | 3.62123692 |
| 26 | Nephronophthisis (HP:0000090) | 3.61613195 |
| 27 | Respiratory difficulties (HP:0002880) | 3.60981412 |
| 28 | Type II lissencephaly (HP:0007260) | 3.54906207 |
| 29 | Aplasia cutis congenita (HP:0001057) | 3.30957055 |
| 30 | Abnormality of the dental root (HP:0006486) | 3.30835268 |
| 31 | Taurodontia (HP:0000679) | 3.30835268 |
| 32 | Abnormality of permanent molar morphology (HP:0011071) | 3.30835268 |
| 33 | Focal motor seizures (HP:0011153) | 3.29797145 |
| 34 | Oligodontia (HP:0000677) | 3.25697121 |
| 35 | Tetraparesis (HP:0002273) | 3.23433781 |
| 36 | Cerebellar dysplasia (HP:0007033) | 3.21337398 |
| 37 | Abnormality of molar (HP:0011077) | 3.21142699 |
| 38 | Abnormality of molar morphology (HP:0011070) | 3.21142699 |
| 39 | Hypoplastic nipples (HP:0002557) | 3.19929587 |
| 40 | Choanal stenosis (HP:0000452) | 3.18856785 |
| 41 | Alopecia of scalp (HP:0002293) | 3.17548564 |
| 42 | Morphological abnormality of the middle ear (HP:0008609) | 3.11607347 |
| 43 | Abnormality of the renal medulla (HP:0100957) | 3.04493037 |
| 44 | Hyperlipoproteinemia (HP:0010980) | 2.91389646 |
| 45 | Abnormality of the dental pulp (HP:0006479) | 2.90286247 |
| 46 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.88306310 |
| 47 | Hyperventilation (HP:0002883) | 2.85142111 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.84116858 |
| 49 | Partial duplication of thumb phalanx (HP:0009944) | 2.80856717 |
| 50 | Prominent supraorbital ridges (HP:0000336) | 2.79847371 |
| 51 | Large for gestational age (HP:0001520) | 2.79277669 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.78284981 |
| 53 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.70886283 |
| 54 | Xerostomia (HP:0000217) | 2.70484625 |
| 55 | Abnormal pupillary function (HP:0007686) | 2.67818218 |
| 56 | Adrenal hypoplasia (HP:0000835) | 2.67587624 |
| 57 | Abnormality of the nasal septum (HP:0000419) | 2.66127704 |
| 58 | Relative macrocephaly (HP:0004482) | 2.65493543 |
| 59 | Severe muscular hypotonia (HP:0006829) | 2.64318438 |
| 60 | Chronic otitis media (HP:0000389) | 2.61972536 |
| 61 | Short tibia (HP:0005736) | 2.61593858 |
| 62 | Hypoplasia of the pons (HP:0012110) | 2.60845222 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.60700848 |
| 64 | Absent hair (HP:0002298) | 2.60331525 |
| 65 | Decreased central vision (HP:0007663) | 2.59700888 |
| 66 | Inability to walk (HP:0002540) | 2.59550962 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.58570682 |
| 68 | Cystic liver disease (HP:0006706) | 2.58341193 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 2.57026695 |
| 70 | Sclerocornea (HP:0000647) | 2.55943328 |
| 71 | Anhidrosis (HP:0000970) | 2.55938007 |
| 72 | Dysphonia (HP:0001618) | 2.54643605 |
| 73 | Furrowed tongue (HP:0000221) | 2.52879093 |
| 74 | Abolished electroretinogram (ERG) (HP:0000550) | 2.52308743 |
| 75 | Turricephaly (HP:0000262) | 2.50925181 |
| 76 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.49990676 |
| 77 | Partial duplication of the phalanx of hand (HP:0009999) | 2.49458347 |
| 78 | Lissencephaly (HP:0001339) | 2.49075618 |
| 79 | Stenosis of the external auditory canal (HP:0000402) | 2.47595142 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.47401259 |
| 81 | Increased CSF lactate (HP:0002490) | 2.46983433 |
| 82 | Brittle hair (HP:0002299) | 2.44915497 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 2.44817100 |
| 84 | Thick nail (HP:0001805) | 2.43036469 |
| 85 | Septate vagina (HP:0001153) | 2.43006539 |
| 86 | Abnormality of the pons (HP:0007361) | 2.42067217 |
| 87 | Visual hallucinations (HP:0002367) | 2.34970143 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.34732020 |
| 89 | Hypomagnesemia (HP:0002917) | 2.33501031 |
| 90 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.32263241 |
| 91 | Congenital, generalized hypertrichosis (HP:0004540) | 2.30473547 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.29958575 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.29958575 |
| 94 | Type I diabetes mellitus (HP:0100651) | 2.29849377 |
| 95 | Broad-based gait (HP:0002136) | 2.29738942 |
| 96 | Renal cortical cysts (HP:0000803) | 2.28969192 |
| 97 | Pachygyria (HP:0001302) | 2.28901721 |
| 98 | Gait imbalance (HP:0002141) | 2.28807661 |
| 99 | Methylmalonic aciduria (HP:0012120) | 2.28136878 |
| 100 | Increased corneal curvature (HP:0100692) | 2.27901653 |
| 101 | Keratoconus (HP:0000563) | 2.27901653 |
| 102 | Thickened helices (HP:0000391) | 2.26979957 |
| 103 | Long foot (HP:0001833) | 2.26495108 |
| 104 | Anencephaly (HP:0002323) | 2.26483764 |
| 105 | Abnormality of salivation (HP:0100755) | 2.26382862 |
| 106 | Progressive cerebellar ataxia (HP:0002073) | 2.25814708 |
| 107 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25422728 |
| 108 | Polyphagia (HP:0002591) | 2.25301157 |
| 109 | Abnormality of the labia minora (HP:0012880) | 2.24677636 |
| 110 | Abnormal number of erythroid precursors (HP:0012131) | 2.24492626 |
| 111 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.23997988 |
| 112 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.22605279 |
| 113 | Acute encephalopathy (HP:0006846) | 2.20662835 |
| 114 | Progressive macrocephaly (HP:0004481) | 2.20025826 |
| 115 | Pendular nystagmus (HP:0012043) | 2.18839425 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 2.15751972 |
| 117 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.15751972 |
| 118 | Xanthomatosis (HP:0000991) | 2.12288036 |
| 119 | Tubular atrophy (HP:0000092) | 2.11046311 |
| 120 | Recurrent corneal erosions (HP:0000495) | 2.10966838 |
| 121 | Hepatic necrosis (HP:0002605) | 2.10755807 |
| 122 | Methylmalonic acidemia (HP:0002912) | 2.10684655 |
| 123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10320796 |
| 124 | Hepatocellular necrosis (HP:0001404) | 2.09092789 |
| 125 | Congenital primary aphakia (HP:0007707) | 2.09032880 |
| 126 | Genetic anticipation (HP:0003743) | 2.07494074 |
| 127 | Polydipsia (HP:0001959) | 2.07277592 |
| 128 | Abnormal drinking behavior (HP:0030082) | 2.07277592 |
| 129 | Status epilepticus (HP:0002133) | 2.05395349 |
| 130 | Hypotrichosis (HP:0001006) | 2.05153160 |
| 131 | Excessive salivation (HP:0003781) | 2.04331980 |
| 132 | Drooling (HP:0002307) | 2.04331980 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 2.03302745 |
| 134 | Abnormality of the musculature of the hand (HP:0001421) | 2.02993127 |
| 135 | Clitoromegaly (HP:0000057) | 2.02583153 |
| 136 | Myokymia (HP:0002411) | 2.02313634 |
| 137 | Alacrima (HP:0000522) | 2.01336976 |
| 138 | Optic disc pallor (HP:0000543) | 2.00788214 |
| 139 | Optic nerve hypoplasia (HP:0000609) | 2.00389534 |
| 140 | Insidious onset (HP:0003587) | 2.00385375 |
| 141 | Termporal pattern (HP:0011008) | 2.00385375 |
| 142 | Absent septum pellucidum (HP:0001331) | 1.99610724 |
| 143 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99437322 |
| 144 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97853772 |
| 145 | Abnormality of the corticospinal tract (HP:0002492) | 1.97382222 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96654178 |
| 147 | Oligodactyly (hands) (HP:0001180) | 1.96288795 |
| 148 | Retinal dysplasia (HP:0007973) | 1.95861693 |
| 149 | Parakeratosis (HP:0001036) | 1.95442414 |
| 150 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.95095188 |
| 151 | Cholelithiasis (HP:0001081) | 1.94388358 |
| 152 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.93738327 |
| 153 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91993933 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.91119701 |
| 155 | Split foot (HP:0001839) | 1.91056499 |
| 156 | Pallor (HP:0000980) | 1.89060497 |
| 157 | Progressive inability to walk (HP:0002505) | 1.88266015 |
| 158 | Congenital hepatic fibrosis (HP:0002612) | 1.85212598 |
| 159 | Atonic seizures (HP:0010819) | 1.85155897 |
| 160 | Abnormality of the parietal bone (HP:0002696) | 1.85037060 |
| 161 | Abnormality of macular pigmentation (HP:0008002) | 1.84672417 |
| 162 | Shallow orbits (HP:0000586) | 1.84426293 |
| 163 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.84030612 |
| 164 | Hypoplasia of the fovea (HP:0007750) | 1.84030612 |
| 165 | Neuroendocrine neoplasm (HP:0100634) | 1.83631821 |
| 166 | Bile duct proliferation (HP:0001408) | 1.83457411 |
| 167 | Abnormal biliary tract physiology (HP:0012439) | 1.83457411 |
| 168 | Occipital encephalocele (HP:0002085) | 1.83174914 |
| 169 | Neuronal loss in central nervous system (HP:0002529) | 1.82459120 |
| 170 | Agitation (HP:0000713) | 1.81808872 |
| 171 | Macrocytic anemia (HP:0001972) | 1.81303335 |
| 172 | Acanthosis nigricans (HP:0000956) | 1.81170463 |
| 173 | Gaze-evoked nystagmus (HP:0000640) | 1.80895556 |
| 174 | Increased serum lactate (HP:0002151) | 1.80116578 |
| 175 | Patellar aplasia (HP:0006443) | 1.79571575 |
| 176 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.78919335 |
| 177 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.78451538 |
| 178 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.78451538 |
| 179 | Hemiparesis (HP:0001269) | 1.78096856 |
| 180 | Mesangial abnormality (HP:0001966) | 1.77746666 |
| 181 | Clumsiness (HP:0002312) | 1.77428692 |
| 182 | Disproportionate short-trunk short stature (HP:0003521) | 1.76867760 |
| 183 | Azoospermia (HP:0000027) | 1.76804480 |
| 184 | Mixed hearing impairment (HP:0000410) | 1.76180078 |
| 185 | Lower limb amyotrophy (HP:0007210) | 1.75911643 |
| 186 | Abnormal gallbladder morphology (HP:0012437) | 1.75250451 |
| 187 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74828003 |
| 188 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.74000214 |
| 189 | Absent speech (HP:0001344) | 1.73921826 |
| 190 | Polyuria (HP:0000103) | 1.73579722 |
| 191 | Pheochromocytoma (HP:0002666) | 1.73483697 |
| 192 | Anophthalmia (HP:0000528) | 1.73093943 |
| 193 | Increased hepatocellular lipid droplets (HP:0006565) | 1.72754594 |
| 194 | Intestinal atresia (HP:0011100) | 1.72262651 |
| 195 | Hypoplastic left heart (HP:0004383) | 1.68906488 |
| 196 | Hypohidrosis (HP:0000966) | 1.68566885 |
| 197 | Broad ribs (HP:0000885) | 1.67941002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 7.52436641 |
| 2 | CAMK1D | 7.29203539 |
| 3 | CAMK1G | 5.49131666 |
| 4 | FRK | 4.16311866 |
| 5 | ADRBK2 | 3.98974075 |
| 6 | CAMKK1 | 3.16620553 |
| 7 | PBK | 3.08569576 |
| 8 | NME1 | 2.58332141 |
| 9 | MAP4K2 | 2.57126145 |
| 10 | ZAK | 2.55969593 |
| 11 | TLK1 | 2.40454449 |
| 12 | FGFR2 | 2.24195700 |
| 13 | PNCK | 2.12962524 |
| 14 | WNK4 | 2.11621579 |
| 15 | EPHA3 | 2.10658326 |
| 16 | MAP3K4 | 2.07195471 |
| 17 | RIPK4 | 2.05112218 |
| 18 | ERBB4 | 1.98751556 |
| 19 | FGR | 1.81047131 |
| 20 | NUAK1 | 1.77973810 |
| 21 | CAMK4 | 1.75532338 |
| 22 | TAOK3 | 1.65092838 |
| 23 | GRK5 | 1.62552027 |
| 24 | ACVR1B | 1.53411565 |
| 25 | GRK7 | 1.46277223 |
| 26 | PDK2 | 1.35657818 |
| 27 | MET | 1.31307254 |
| 28 | CAMK1 | 1.24335642 |
| 29 | FES | 1.19605055 |
| 30 | CSNK1G2 | 1.19335877 |
| 31 | CSNK1G1 | 1.14748047 |
| 32 | OXSR1 | 1.14542210 |
| 33 | EPHB2 | 1.14309246 |
| 34 | MOS | 1.14041603 |
| 35 | TBK1 | 1.11681314 |
| 36 | CASK | 1.11118020 |
| 37 | CSNK1G3 | 1.08297461 |
| 38 | TGFBR2 | 1.04231144 |
| 39 | DAPK2 | 1.02783907 |
| 40 | BCKDK | 0.99685264 |
| 41 | SIK2 | 0.94305052 |
| 42 | TIE1 | 0.94147664 |
| 43 | MAP3K9 | 0.94128914 |
| 44 | LRRK2 | 0.93725777 |
| 45 | RPS6KA4 | 0.93603260 |
| 46 | LIMK1 | 0.93422376 |
| 47 | NTRK2 | 0.91071775 |
| 48 | EPHA4 | 0.89956135 |
| 49 | ADRBK1 | 0.89202829 |
| 50 | MAPK15 | 0.89120189 |
| 51 | CSNK1A1L | 0.86286573 |
| 52 | PIM2 | 0.85536604 |
| 53 | VRK1 | 0.85286754 |
| 54 | NTRK3 | 0.85041524 |
| 55 | VRK2 | 0.81053807 |
| 56 | MARK1 | 0.80821834 |
| 57 | IRAK1 | 0.80037723 |
| 58 | BMPR2 | 0.80026488 |
| 59 | STK39 | 0.78936137 |
| 60 | PASK | 0.76543470 |
| 61 | PKN1 | 0.74517896 |
| 62 | BCR | 0.73432966 |
| 63 | SIK3 | 0.73273666 |
| 64 | MAP2K6 | 0.72444028 |
| 65 | PRKCQ | 0.70551481 |
| 66 | BMPR1B | 0.70483542 |
| 67 | INSRR | 0.70398346 |
| 68 | SIK1 | 0.68893306 |
| 69 | MKNK2 | 0.67067714 |
| 70 | TAF1 | 0.66225346 |
| 71 | CDK5 | 0.64794063 |
| 72 | TRIM28 | 0.62891231 |
| 73 | PRKCE | 0.62882595 |
| 74 | CAMK2B | 0.62280156 |
| 75 | STK16 | 0.60746396 |
| 76 | BLK | 0.59955805 |
| 77 | PAK6 | 0.59821725 |
| 78 | RIPK1 | 0.59170173 |
| 79 | TGFBR1 | 0.58229676 |
| 80 | MAP2K7 | 0.56619652 |
| 81 | PIK3CA | 0.55711914 |
| 82 | PRKCI | 0.53511777 |
| 83 | MAPKAPK5 | 0.50408498 |
| 84 | MST1R | 0.50038550 |
| 85 | WNK1 | 0.48747287 |
| 86 | UHMK1 | 0.46923330 |
| 87 | PTK2B | 0.46669659 |
| 88 | JAK3 | 0.44829057 |
| 89 | AKT3 | 0.44423767 |
| 90 | MAP2K4 | 0.43423601 |
| 91 | CSNK1A1 | 0.42876655 |
| 92 | CAMK2A | 0.42157802 |
| 93 | RPS6KA5 | 0.42068707 |
| 94 | TXK | 0.41173072 |
| 95 | CSNK1D | 0.39261919 |
| 96 | PLK2 | 0.38871225 |
| 97 | TNIK | 0.38044725 |
| 98 | FER | 0.35339113 |
| 99 | ERBB2 | 0.34911427 |
| 100 | FYN | 0.34400460 |
| 101 | MAPK12 | 0.33404251 |
| 102 | CHUK | 0.33364006 |
| 103 | PRKAA1 | 0.33074120 |
| 104 | MKNK1 | 0.31411200 |
| 105 | ARAF | 0.31377701 |
| 106 | MAPK13 | 0.30332576 |
| 107 | DYRK3 | 0.30116246 |
| 108 | KSR1 | 0.30043462 |
| 109 | FGFR1 | 0.29938974 |
| 110 | SGK223 | 0.29546393 |
| 111 | SGK494 | 0.29546393 |
| 112 | PAK3 | 0.29200461 |
| 113 | PRKCA | 0.29121796 |
| 114 | RAF1 | 0.28942073 |
| 115 | CDK3 | 0.28837700 |
| 116 | MAP3K6 | 0.28699568 |
| 117 | DYRK2 | 0.28522360 |
| 118 | PLK1 | 0.28082314 |
| 119 | CAMK2G | 0.27914595 |
| 120 | DYRK1A | 0.27813699 |
| 121 | EIF2AK3 | 0.27639055 |
| 122 | FLT3 | 0.27571888 |
| 123 | PINK1 | 0.27510209 |
| 124 | CAMK2D | 0.27479556 |
| 125 | IKBKB | 0.27467468 |
| 126 | TYRO3 | 0.26528548 |
| 127 | PLK3 | 0.25833372 |
| 128 | STK11 | 0.25601041 |
| 129 | PRKCG | 0.24981314 |
| 130 | PRKCH | 0.24151180 |
| 131 | ICK | 0.23703246 |
| 132 | KSR2 | 0.23244767 |
| 133 | TTN | 0.22308329 |
| 134 | MINK1 | 0.21810104 |
| 135 | MUSK | 0.21011236 |
| 136 | GRK1 | 0.18466873 |
| 137 | PRKACG | 0.18021589 |
| 138 | RPS6KA2 | 0.17576899 |
| 139 | PRKCZ | 0.16621364 |
| 140 | EPHA2 | 0.16586880 |
| 141 | SYK | 0.16429445 |
| 142 | PRKACA | 0.15919578 |
| 143 | PDK1 | 0.15108246 |
| 144 | EPHB1 | 0.14838082 |
| 145 | STK10 | 0.14561985 |
| 146 | PAK2 | 0.14542376 |
| 147 | PHKG1 | 0.14293446 |
| 148 | PHKG2 | 0.14293446 |
| 149 | SRC | 0.14191567 |
| 150 | WNK3 | 0.14180017 |
| 151 | PRKCB | 0.14108928 |
| 152 | SGK2 | 0.13825816 |
| 153 | IKBKE | 0.12463146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.17604240 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.24791724 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.15466478 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.87289061 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.81721795 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.64801189 |
| 7 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.60133912 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.39432705 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.30603606 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.26805890 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04464909 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98989044 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96054244 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90881763 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.89942681 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.82094408 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.76017913 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74775065 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71324100 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.70332425 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69179966 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.67848218 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62949917 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62263462 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56283581 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54083054 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52467263 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.51513889 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.46956358 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45591800 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.43566221 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41913675 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41717587 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41575211 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.40929706 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.38167887 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30639660 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29834089 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.24963262 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23289252 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21660456 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19731942 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19390756 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.19101992 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17356149 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17347453 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 1.15378508 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.14419331 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13730678 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.11343527 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09866336 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09852521 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09718434 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.07547348 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06870997 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05799236 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05614064 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05581212 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03971471 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03945295 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03693119 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03402453 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.02876578 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00869896 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00832723 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 1.00804525 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00256557 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.94866565 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93943221 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93873954 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93740723 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93120045 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93016163 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.91562102 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90571832 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.90537395 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.89253290 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.88830847 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.87724676 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86591958 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86410010 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85194235 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84009645 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81227488 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80830160 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80658906 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80254654 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79738702 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79148693 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76427533 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76259940 |
| 92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73664188 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73610188 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73029660 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72476020 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71303420 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70915441 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70578702 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69279823 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69154428 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67854413 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67667788 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.67011425 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61596697 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61038186 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60496815 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59925658 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.59753920 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59304434 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.58481676 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57969848 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57229205 |
| 113 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56988120 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56158276 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54644458 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54510638 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54175910 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53984592 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52117347 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52047367 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51602739 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49287266 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47431441 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47382429 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47185854 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46766405 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46573191 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.46404227 |
| 129 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45007204 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44964176 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.44681608 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44288163 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.44019500 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43207570 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42593450 |
| 136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42398825 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.40558517 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40312532 |
| 139 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40218263 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38899572 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.37393124 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36671533 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36585405 |
| 144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36486003 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36170934 |
| 146 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36145975 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34956719 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34165575 |
| 149 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33945995 |
| 150 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33815373 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33121276 |
| 152 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33118416 |
| 153 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32613194 |

